{"version":"1.0","provider_name":"South Africa Voice","provider_url":"https:\/\/southafricavoice.com","author_name":"South Africa Voice","author_url":"https:\/\/southafricavoice.com\/author\/southafricavoice01\/","title":"GenScript Biotech annonce ses r\u00e9sultats du premier semestre 2021 - South Africa Voice","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"njJ79yPoWw\"><a href=\"https:\/\/southafricavoice.com\/genscript-biotech-annonce-ses-resultats-du-premier-semestre-2021-2\/\">GenScript Biotech annonce ses r\u00e9sultats du premier semestre 2021<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/southafricavoice.com\/genscript-biotech-annonce-ses-resultats-du-premier-semestre-2021-2\/embed\/#?secret=njJ79yPoWw\" width=\"600\" height=\"338\" title=\"&#8220;GenScript Biotech annonce ses r\u00e9sultats du premier semestre 2021&#8221; &#8212; South Africa Voice\" data-secret=\"njJ79yPoWw\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"L\u2019entreprise affiche une croissance explosive de l\u2019activit\u00e9 d\u2019organisation de d\u00e9veloppement et de fabrication sous contrat (CDMO) de th\u00e9rapie g\u00e9nique et cellulaire (GCT) et des investissements strat\u00e9giques en th\u00e9rapie g\u00e9nique et cellulaire NANJING, Chine, 25 ao\u00fbt\u00a02021 \/PRNewswire\/ \u2014 GenScript Biotech Corporation (HKEX: 1548.HK) (GenScript) a publi\u00e9 aujourd\u2019hui ses r\u00e9sultats financiers du premier semestre 2021 pour le [\u2026]"}